Monday 24th December 2012 |
Text too small? |
Todd Corp, the investment company of New Zealand's wealthiest family, has acquired a 19.9 percent stake in Wolf Minerals as part of a placement to help fund the ASX-listed company's development of a Tungsten mine in southwest England.
TTI (NZ), a unit of Todd, subscribed for 39.4 million shares in Wolf at 27 cents apiece, a 12 percent premium to Wolf's 30-day volume-weighted average price, the Perth-based company said in a statement to the ASX. It may acquire more shares in 2013.
In total Wolf raised A$20.3 million in a placement of 75.4 million shares including to existing major shareholders Resource Capital Fund V, a Denver-based private equity fund, and Traxys Projects, a specialist financier for resource projects.
Wolf, whose shares trade on both the ASX and London's AIM market, is focused on developing the Hemerdon Tungsten and Tin Project in Devon, which it says is one the largest undeveloped tungsten and tin resources in the western world. Wolf holds an option over 100 percent of the project.
The placement is a key condition of a US$75 million bridge finance facility and US$7 million royalty from RCF, which has provided funding to allow the project to start. The royalty payment is an advance payment on 2 percent of gross revenue from the project which RCF has acquired.
Wolf needs to raise additional equity in 2013 of about 45 million pounds to repay the bridging finance and has been in talks with both RCF and Todd to take up about 25 million pounds of that.
Shares of Wolf last traded at 27.5 Australian cents on the ASX, valuing the company at A$31.4 million, and have climbed 25 percent in the past month. Because of the size of the capital raising, the plan requires approval of shareholders at a meeting in Perth on Jan. 24.
BusinessDesk.co.nz
No comments yet
FBU - Fletcher Building Announces Director Appointment
December 23rd Morning Report
MWE - Suspension of Trading and Delisting
EBOS welcomes finalisation of First PWA
CVT - AMENDED: Bank covenant waiver and trading update
Gentrack Annual Report 2024
December 20th Morning Report
Rua Bioscience announces launch of new products in the UK
TEM - Appointment to the Board of Directors
December 19th Morning Report